study analyzed 2220 multiple myeloma patients (2380 samples) using 10 independent GEO datasets with different bioinformatics analysis methods and found that CCT3 was significantly overexpressed in multiple myeloma patients and that CCT3 overexpression was a poor predictor of survival, and its functional intensity was positively correlated with disease progression. Here, CCT3 is linked to plasma cell myeloma.